ArticleOnline now102946Open access Affiliations & Notes 1Gladstone Institutes, University of California, San Francisco, San Francisco, CA, United States of America 2Department of Urology, University of California, San Francisco, San Francisco, CA, United States of America 3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America 4Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Heeju Ryu
Cell Simulation as Cell Segmentation
Abstract Single-cell spatial transcriptomics promises a highly detailed view of a cell's transcriptional state and microenvironment, yet inaccurate cell segmentation can render this data murky by misattributing large numbers of transcripts to nearby cells or conjuring nonexistent cells. We adopt methods from ab initio cell simulation to rapidly infer morphologically plausible cell boundaries that preserve cell type heterogeneity.
Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma
Highlights • MCPyV-specific CD8 T cells in blood predict MCC patient response to anti-PD-1 • Blood MCPyV-specific CD8 T cells often express CD39, CLA, or CD103 • Bulk CD39+CLA+ CD8 T cells predict response to anti-PD-1 • Bulk CD39+CD103+ CD8 T cells correlate with tumor burden and predict poor outcomes Summary Merkel cell carcinoma is a skin cancer often driven by Merkel cell polyomavirus (MCPyV) with high rates of response to anti-PD-1 therapy despite low mutational burden.
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma
Highlights • Frequency of anti-tumor CD8 T cells at baseline in blood predicts anti-PD-1 response • Frequency of anti-tumor CD8 T cells in the tumor does not predict anti-PD-1 response • Intratumoral CD8 T cells are more dysfunctional than their peripheral counterparts • HLA-I downregulation is a mechanism of secondary resistance to anti-PD-1 in MCC Summary Understanding cancer immunobiology has been hampered by difficulty identifying cancer-specific T cells.
Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence
Key Points Longitudinal CyTOF analysis of tetramer+ SARS-CoV-2–specific CD8+ T cells was performed. Nucleocapsid-specific T and Ab responses are coordinated. Self-renewing potential and polyfunctionality of tetramer+ cells change over convalescence. Abstract CD8+ T cells can potentiate long-lived immunity against COVID-19.
Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence
Tongcui Ma, Heeju Ryu, Matthew McGregor, Benjamin Babcock, Jason Neidleman, Guorui Xie, Ashley F. George, Julie Frouard, Victoria Murray, Gurjot Gill, Eliver Ghosn, Evan W. Newell, Sulggi A. Lee and Nadia R. Roan J Immunol August 13, 2021, ji2100465; DOI: https://doi.org/10.4049/jimmunol.2100465 Key Points Longitudinal CyTOF analysis of tetramer+ SARS-CoV-2–specific CD8+ T cells was performed. Nucleocapsid-specific T and Ab responses are coordinated.
Protracted yet coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ T cells during COVID-19 convalescence
New Results Tongcui Ma, Heeju Ryu, Matthew McGregor, Benjamin Babcock, Jason Neidleman, Guorui Xie, Ashley F. George, Julie Frouard, Victoria Murray, Gurjot Gill, Eliver Ghosn, Evan Newell, Sulggi Lee, Nadia R. Roan doi: https://doi.org/10.1101/2021.04.28.441880 ABSTRACT CD8+ T cells are important antiviral effectors that can potentiate long-lived immunity against COVID-19, but a detailed characterization of these cells has been hampered by technical challenges.
Publisher Correction: Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27
In the version of this article initially published, the third label along the horizontal axis of Fig. 4b (Il13a) and the middle label above each plot in Fig. 6k (Stat–/–) were incorrect, and the hash marks along the horizontal axis for Fig. 6i were spaced incorrectly. Also, the statistical results in the citation for Supplementary Fig. 5a (*P < 0.05, **P < 0.01 and ***P < 0.001 (unpaired Student’s t-test)) in the fifth subsection of Results were incorrect. The correct label for Fig.
Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27
(a) Mice were generated and treated as described in Fig. 6. Levels of total IgG, IgG1 and IgG2c in the sera of the indicated mice. (b,c) Mice were generated and treated as described in Supplementary Figure 2a,b. Levels of collagen-specific antibodies in the sera (b). Flow cytometric analysis of germinal center B cells, plasma cell and T cells in the lymph nodes of the indicated mice (c). Data are one representative experiment of three independent experiments with n=5 per group.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Heeju
Contact Heeju, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack